Cigna Group $CI Shares Sold by Procyon Advisors LLC

Procyon Advisors LLC lowered its holdings in Cigna Group (NYSE:CI) by 74.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,071 shares of the health services provider’s stock after selling 3,069 shares during the period. Procyon Advisors LLC’s holdings in Cigna Group were worth $295,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the business. Harbor Capital Advisors Inc. increased its holdings in Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares during the last quarter. Collier Financial purchased a new position in shares of Cigna Group during the 3rd quarter valued at approximately $34,000. Founders Capital Management grew its position in shares of Cigna Group by 53.0% during the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock worth $44,000 after buying an additional 53 shares in the last quarter. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of Cigna Group during the second quarter worth approximately $52,000. Finally, Measured Wealth Private Client Group LLC bought a new stake in shares of Cigna Group in the third quarter worth $56,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Up 1.6%

CI stock opened at $265.78 on Wednesday. The firm has a market cap of $70.04 billion, a price-to-earnings ratio of 11.98, a PEG ratio of 0.91 and a beta of 0.27. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The firm has a fifty day moving average price of $277.46 and a two-hundred day moving average price of $280.87. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. During the same period last year, the firm posted $6.64 EPS. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Research analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were issued a $1.56 dividend. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend was Thursday, March 5th. Cigna Group’s dividend payout ratio is 28.13%.

Analysts Set New Price Targets

Several research firms recently issued reports on CI. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research note on Tuesday, February 10th. UBS Group reissued a “buy” rating and issued a $375.00 target price on shares of Cigna Group in a research report on Monday, February 9th. Jefferies Financial Group increased their price target on shares of Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Finally, Leerink Partners boosted their price objective on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $333.11.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This represents a 23.26% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.